Penguin Solutions: Aiming to Address Inference Memory Bottleneck yet Growth to Flatline in FQ4

Penguin Solutions has come across our radar for a handful of reasons, with the first being that it is a smaller player in the memory market with a unique approach to CXL-based memory solutions (as we detailed in our early July newsletter series on offload engines and improving inference economics), as well as its strong YTD performance. Shares in Penguin have risen 159% YTD and 212% since its low at the end of March, far outperforming the market, with a favorable technical setup. Fundamentally, Penguin reported rapid YoY and QoQ growth in its memory segment, though this growth is dragged down by softer performance in its AI server and LED segments. Topline growth appears to be rather fleeting – management’s raised guidance for FY26 implies growth essentially flatlining sequentially into Q4. Management offered no indication there would be a sharp reacceleration (yet) in FY27. However, that could change given Penguin is at the forefront of addressing the additional memory and orchestration requirements driven by agentic AI and inference. The company has designed its MemoryAI KV Cache server to offload KV cache into lower-cost, CXL-attached memory, helping support larger context windows during inference tasks. Combined with a few other products, such as their core product CXL memory cards, the company is seeking to monetize the memory boom as a platform by combining hardware with operational software. Penguin is certainly in the right place, and its $2.5B market cap means even small wins could help move the stock. However, at this early stage, execution is entirely unknown, and there is a long list of well-established competitors in the space (Dell, Super Micro, HP, among others including a sizable list of Chinese server companies). Therefore, technicals are needed to help offset the risk that Penguin identifies the right bottleneck but does not capture enough of the market. The opposite could also happen to where Penguin executes well; point being, the evidence is not in the financials just yet.